跳至主要内容
临床试验/2024-518764-13-00
2024-518764-13-00已完成1 期

A Phase I, randomized, controlled, Latin-square, open-label study, to evaluate the effect of ADV7103 on gastric pH under fed and fasting conditions in adult healthy participants.

Advicenne1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2025年2月19日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
Advicenne
入组人数
12
试验地点
1

研究概览

简要总结

暂无简介。

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Advicenne
申办方类型
Pharmaceutical company
责任方
Principal Investigator
主要研究者

Didier Laurens, Chief Executive Officer

Scientific

Advicenne

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
A study to evaluate the safety and the efficacy of a sterile bio-compatible patch (sFilm-FS) in controlling bleeding during hepatic surgery.
EUCTR2018-000434-34-SISealantium Medical Ltd.30
进行中(未招募)
1 期
A study to evaluate the safety and the efficacy of a sterile bio-compatible patch (sFilm-FS) in controlling bleeding during hepatic surgery.Open hepatic surgery, with presence of an target bleeding site (TBS).MedDRA version: 21.1Level: LLTClassification code 10067440Term: HemostasisSystem Organ Class: 100000004865
EUCTR2018-000434-34-ATSealantium Medical Ltd.30
进行中(未招募)
不适用
A phase I/II, randomized, single blind, controlled study in adults aged 18-60 years to evaluate the immunogenicity, safety and reactogenicity of an adjuvanted influenza vaccine candidate (GSK 2115160A). - FLU-D-QIV-001 PRIImmunization of healthy adults aged 18 to 60 years against influenza
EUCTR2008-001303-34-CZGlaxoSmithKline Biologicals
已完成
不适用
Study of egg-derived influenza vaccine and cell culture-derived influenza vaccine in healthy adult volunteersDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
KCT0001240SK Chemicals100
招募中
1 期
A study on the safety and immune response of AS37 together with Hepatitis B antigen in adults aged 18-45 yearsHealthy volunteers (Hepatitis B Virus infection)MedDRA version: 20.0Level: PTClassification code 10019731Term: Hepatitis BSystem Organ Class: 10021881 - Infections and infestations
EUCTR2021-005629-25-BEGlaxoSmithKline Biologicals SA150